Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study
Sirpa Leppa,Judit M. Jørgensen,Marja-Liisa Karjalainen-Lindsberg,Klaus Beiske,Mette Pedersen,Kristina Drott,Annika Pasanen,Kristiina Karihtala,Susanna Mannisto,Leo Meriranta, Bente Wold,Marianne Brodtkorb,Unn Merete Fagerli,Thomas S. Larsen,Lars Munksgaard,Kaisa Sunela,Øystein Fluge,Sirkku Jyrkkio,Peter de Nully Brown,Harald Holte Blood（2022）
关键词
treatment strategy,biomarker-driven,high-risk,b-cell
AI 理解论文
溯源树
样例
